Dermatology Medical News about diabetic foot infections; granulocyte-colony stimulating factors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections
Cochrane Reviews, 07/28/09

Cruciani M et al. – People with diabetes can develop foot infections which can be difficult to treat, and treatment failure can result in lower extremity amputation. The authors found five trials which included a total of 167 people. The trials showed that adding G–CSF to usual therapy did not significantly affect the likelihood of the infection resolving or the improved healing of foot wounds, nor did it reduce the period of treatment with oral antibiotics. However, G–CSF does appear to reduce the need for surgical interventions, especially amputations, and the number of days spent in hospital. There are limitations to this analysis related to the variations in the people included in the studies (e.g., the severity of infection, the timing of the clinical assessment, the use of different G–CSF preparations, and for different lengths of time). Therefore caution is required in the interpretation of the findings.

<< Previous
Leprosy: A Diagnostic Trap for Dermatopathologists in Nonendemic...

Next >>
Hair Care Practices in African-American Patients

The treatment of diabetic foot infections: focus on ertapenem
Vascular Health and Risk Management, 11/09/09 Relevance Score: 83%

Exploring the complex care of the diabetic foot ulcer
JAAPA, 10/30/09 Relevance Score: 82%

Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
PharmacoEconomics, 11/17/09 Relevance Score: 80%

Hyperbaric oxygen therapy as an anti-infective agent
Expert Review of Anti-infective Therapy, 10/21/09 Relevance Score: 80%

Diabetic Foot Infections
Journal of the American Podiatric Medical Association, 10/05/09 Relevance Score: 80%